MeCP2 phosphorylation limits psychostimulant-induced behavioral and neuronal plasticity.

Area of Science:

• Neuroscience
• Molecular Biology
• Addiction Research

Background:

• Methyl-CpG binding protein 2 (MeCP2) regulates gene expression and is implicated in drug reinforcement.
• Psychostimulants like amphetamine and cocaine induce MeCP2 phosphorylation at Serine 421 (Ser421).
• The functional role of MeCP2 Ser421 phosphorylation in addictive behaviors remained unclear.

Purpose of the Study:

• To investigate the functional significance of MeCP2 phosphorylation at Ser421 for addictive-like behaviors.
• To determine how MeCP2 Ser421 phosphorylation impacts neural circuits and gene expression in response to psychostimulants.

Main Methods:

• Generation of MeCP2 Ser421Ala knock-in mice, where Ser421 phosphorylation is prevented.
• Assessment of behavioral responses to amphetamine (locomotor sensitization) and cocaine (self-administration).
• Electrophysiological recordings of medium spiny neuron intrinsic excitability and analysis of nucleus accumbens gene expression.

Main Results:

• MeCP2 Ser421Ala knock-in mice exhibited a lower threshold for amphetamine-induced locomotor sensitization.
• These mice showed increased behavioral sensitivity to the reinforcing effects of self-administered cocaine.
• Knock-in mice displayed altered medium spiny neuron excitability and nucleus accumbens gene expression patterns similar to those seen after repeated drug exposure.

Conclusions:

• Phosphorylation of MeCP2 at Ser421 acts as a crucial brake on the development of addictive-like behaviors.
• This phosphorylation event limits the nucleus accumbens circuit plasticity that underlies psychostimulant addiction.
• Targeting MeCP2 Ser421 phosphorylation may offer novel therapeutic strategies for addiction treatment.